canin
parvoviru
type
emerg
late
caus
sever
epizoot
kennel
dog
shelter
worldwid
soon
emerg
underw
genet
evolut
give
rise
consecut
two
antigen
variant
replac
progress
origin
type
new
antigen
variant
detect
itali
rapidli
spread
sever
countri
comparison
origin
type
antigen
variant
display
increas
pathogen
dog
extend
host
rang
abl
infect
caus
diseas
cat
epidemiolog
survey
indic
newest
type
becom
preval
differ
geograph
region
often
associ
sever
diseas
adult
dog
also
dog
complet
vaccin
protocol
howev
primari
caus
failur
cpv
vaccin
interfer
matern
deriv
immun
diagnosi
cpv
infect
tradit
method
shown
poorli
sensit
especi
late
stage
infect
new
diagnost
approach
base
molecular
method
develop
sensit
detect
cpv
clinic
sampl
rapid
characteris
viral
type
continu
surveil
help
assess
whether
real
need
updat
current
avail
vaccin
diagnost
test
elsevi
bv
right
reserv
overview
canin
parvoviru
famili
parvovirida
compris
two
subfamili
parvovirina
densovirina
infect
vertebr
insect
respect
current
five
genera
includ
subfamili
parvovirina
name
parvoviru
erythroviru
dependoviru
amdoviru
bocaviru
canin
parvoviru
cpv
belong
genu
parvoviru
includ
uniqu
speci
felin
panleukopenia
viru
togeth
felin
panleukopenia
viru
fpv
mink
enter
viru
mev
raccoon
parvoviru
rpv
tattersal
et
al
cpv
genet
antigen
unrel
canin
minut
viru
cnmv
formerli
known
canin
parvoviru
type
respons
neonat
death
dog
includ
genu
bocaviru
togeth
bovin
parvoviru
human
bocaviru
tattersal
et
al
parvovirus
small
diamet
nm
nonenvelop
virus
infect
vertebr
insect
parvoviru
virion
consist
spheric
capsid
compos
three
protein
contain
linear
singlestrand
dna
molecul
muzyczka
bern
mean
xray
crystallographi
parvoviru
capsid
found
form
copi
combin
contain
fulllength
sequenc
plu
addit
ntermin
domain
abund
structur
protein
account
viral
capsid
repres
major
determin
host
rang
virushost
interact
cleav
host
proteas
capsid
protein
subunit
made
core
eightstrand
antiparallel
bbarrel
domain
loop
insert
strand
form
larg
spikelik
protrus
surround
icosahedr
threefold
axe
characterist
featur
parvovir
capsid
includ
canyonlik
depress
fivefold
axe
dimplelik
depress
icosahedr
twofold
axe
parvovir
genom
consist
dna
molecul
contain
two
larg
open
read
frame
orf
smaller
overlap
gene
encod
two
nonstructur
two
structur
protein
altern
splice
mrna
viru
replic
take
place
cell
nuclei
requir
rapidli
divid
cell
fetus
newborn
hematopoiet
intestin
tissu
young
adult
anim
replic
vivo
rare
associ
appear
nuclear
inclus
bodi
wherea
cytopath
effect
induc
vitro
alway
evid
parvovirus
highli
stabl
environ
extrem
resist
ph
temperatur
chang
treatment
lipid
solvent
trypsin
disinfect
virion
inactiv
formalin
sodium
hypochlorit
beta
propiolacton
hydroxylamin
oxid
agent
ultraviolet
irradi
sever
parvovirus
abl
agglutin
erythrocyt
differ
mammal
bird
speci
diagnost
test
parvoviru
infect
reli
hemagglutin
activ
muzyczka
bern
truyen
origin
viral
strain
design
distinguish
novel
viru
previouslyknown
caus
sever
fatal
epizoot
hemorrhag
gastroenter
subacut
myocard
kennel
shelter
worldwid
truyen
least
six
seven
amino
acid
aa
chang
fpv
tabl
mostli
accumul
domain
interact
hostcel
transferrin
receptor
tfr
chang
may
contribut
gain
affin
canin
tfr
observ
shift
fpv
fpvlike
parvoviru
shackelton
et
al
anoth
import
differ
two
carnivor
parvovirus
cpv
evolv
much
rapidli
fpv
battilani
et
al
decaro
et
al
decaro
et
al
show
genom
substitut
rate
similar
rna
virus
valu
substitut
per
site
per
year
shackelton
et
al
activ
viru
circul
initi
vaccin
programm
help
develop
herd
immun
canin
popul
greatli
reduc
mortal
spread
viru
howev
hostimmun
pressur
may
also
contribut
progress
emerg
antigen
variant
two
antigen
variant
distinguish
use
monoclon
antibodi
mab
emerg
within
year
term
cpv
type
current
antigen
variant
complet
replac
origin
type
still
use
commerci
vaccin
various
distribut
canin
popul
worldwid
differ
origin
strain
five
six
aa
residu
capsid
protein
tabl
contrast
two
residu
differenti
ie
truyen
residu
situat
epitop
threefold
spike
capsid
role
antigen
escap
assign
residu
parvoviru
minut
viru
mice
residu
old
type
cpv
display
isoleucin
residu
differenti
variant
strain
exhibit
subsequ
introduct
chang
recent
strain
differ
posit
protein
tabl
martella
et
al
decaro
et
al
mutat
occur
last
decad
fix
type
cpv
includ
residu
locat
middl
epitop
b
substitut
posit
may
respons
chang
antigen
cpv
variant
truyen
chang
report
worldwid
kapil
et
al
kang
et
al
decaro
et
al
implic
clearli
understood
major
chang
affect
region
compris
residu
form
gh
loop
locat
bg
bh
strand
affect
greatest
variabl
among
parvovirus
due
exposur
capsid
surfac
cpv
recogn
target
tissu
viral
replic
intestin
crypt
lymphoid
organ
viru
spread
tissu
pollock
includ
brain
elia
et
al
decaro
et
al
penetr
oronas
rout
viru
replic
gastroenter
associ
lymphoid
tissu
dissemin
infect
leukocyt
germin
epithelium
crypt
small
intestin
caus
diarrhea
infect
leukocyt
mainli
circul
tissueassoci
lymphocyt
induc
acut
lymphopenia
often
associ
neutropenia
pollock
seroneg
pup
cpv
also
abl
replic
cardiac
cell
induc
fatal
myocard
howev
form
longer
observ
almost
young
pup
protect
matern
deriv
antibodi
mda
green
decaro
press
characterist
clinic
form
induc
cpv
repres
hemorrhag
enter
extent
often
depend
mda
titer
infect
pup
moment
infect
clinic
sign
occur
incub
period
day
consist
anorexia
depress
vomit
mucoid
bloodi
diarrhea
frequent
dehydr
fever
leukopenia
constant
find
white
blood
cell
wbc
count
drop
cellsml
blood
howev
total
wbc
count
may
even
within
normal
rang
due
concomit
virusinduc
lymphopenia
neutrophilia
consequ
infect
opportunist
bacteria
concurr
pulmonari
infect
may
lead
onset
respiratori
distress
subclin
inappar
infect
frequent
detect
mainli
pup
intermedi
mda
titer
adult
dog
decaro
et
al
mortal
rate
high
pup
usual
less
adult
dog
hemorrhag
enter
small
intestin
enlarg
mesenter
lymph
node
peyer
patch
main
gross
lesion
observ
dog
tabl
amino
acid
variat
protein
felin
canin
parvovirus
aa
residu
codon
affect
snp
use
design
typespecif
probe
differenti
c
codon
affect
snp
use
design
typespecif
probe
differenti
die
consequ
cpv
infect
histopatholog
small
intestin
affect
multifoc
crypt
necrosi
intranuclear
inclus
bodi
wherea
extens
deplet
lymphocyt
seen
peyer
patch
lymph
node
spleen
thymu
green
decaro
press
prophylaxi
cpv
infect
reli
mainli
extens
vaccin
sinc
inactiv
vaccin
abl
induc
shortterm
immun
modifi
live
viru
mlv
vaccin
wide
use
vaccin
prepar
use
either
origin
type
variant
highli
effect
abl
protect
dog
parvovir
diseas
well
infect
almost
complet
safe
postvaccin
reaction
rare
observ
recent
studi
show
dog
develop
parvoviruslik
diarrhea
vaccin
infect
field
viru
alon
attenu
vaccin
viru
decaro
et
al
primari
caus
failur
cpv
vaccin
interf
level
mda
transmit
bitch
offspr
colostrum
lesser
extent
milk
thu
order
avoid
interfer
activ
immunis
vaccin
administ
pup
wane
mda
green
decaro
press
differ
strategi
propos
overcom
mda
interfer
includ
hightit
vaccin
burtonboy
et
al
intranas
vaccin
vaccin
guidelin
group
world
small
anim
veterinari
associ
also
recommend
delay
finish
primari
cpv
vaccin
cours
week
age
ensur
protect
even
pup
longlast
mda
addit
concern
complet
efficaci
type
vaccin
antigen
variant
kapil
et
al
decaro
et
al
decaro
et
al
new
antigen
type
cpv
detect
itali
fecal
sampl
two
dog
hemorrhag
enter
test
posit
cpv
hemagglutin
ha
strain
characteris
basi
reactiv
monoclon
antibodi
mab
result
genotyp
polymeras
chain
reaction
pcr
howev
sequenc
analysi
larg
fragment
gene
two
strain
found
contain
two
unexpect
amino
acid
variat
respect
classic
type
cpv
chang
residu
share
type
cpv
circul
current
truyen
substitut
due
singl
nucleotid
chang
third
codon
posit
observ
previous
situat
epitop
threefold
spike
capsid
subsequ
virus
share
unusu
mutat
firstli
name
mutant
detect
high
frequenc
itali
decaro
et
al
decaro
et
al
found
worldwid
distribut
nakamura
et
al
decaro
et
al
decaro
et
al
decaro
et
al
hong
et
al
kapil
et
al
perez
et
al
vieira
et
al
touihri
et
al
nandi
et
al
ntafi
et
al
filipov
et
al
widespread
distribut
mutant
pose
taxonom
issu
mutant
propos
new
variant
decaro
et
al
howev
design
previous
assign
cpv
strain
detect
domest
wild
felid
southern
asia
mutant
strain
display
novel
substitut
irrespect
antigen
type
refer
c
c
basi
aa
encount
residu
asn
asp
protein
ikeda
et
al
mutat
residu
associ
adapt
cpv
variant
felin
host
ikeda
et
al
indic
appear
chang
cpv
mutant
consecut
passag
felin
cell
vitro
although
chang
recent
report
dog
korea
kang
et
al
absent
cpv
variant
strain
sequenc
sever
studi
conduct
differ
part
world
meer
et
al
ohshima
et
al
decaro
et
al
thu
restrict
circul
mutant
southeast
asia
contrast
mutant
spread
effici
canin
popul
itali
report
part
world
moreov
although
mutat
locat
middl
antigen
site
b
control
bind
mani
antibodi
capsid
previous
taken
account
classif
variant
truyen
basi
consider
mutant
tent
design
true
antigen
variant
wherea
cpv
regard
mutant
decaro
et
al
recent
develop
realtim
pcr
assay
base
minor
groov
binder
mgb
probe
technolog
led
consider
simplif
diagnost
approach
cpv
characteris
typespecif
mgb
probe
assay
employ
characteris
cpvposit
sampl
collect
itali
decad
find
type
type
type
cpv
retrospect
analysi
reveal
present
itali
frequenc
variant
underw
rapid
fluctuat
year
replac
rapidli
detect
rare
itali
last
year
decaro
et
al
recent
new
variant
detect
sever
countri
epidemiolog
survey
cpv
nakamura
et
al
found
strain
vietnam
variant
isol
outbreak
fatal
gastroenter
occur
breed
kennel
basset
hound
locat
catalonia
spain
decaro
et
al
result
two
differ
european
epidemiolog
survey
decaro
et
al
decaro
et
al
show
predomin
itali
germani
spain
also
wide
distribut
portug
franc
belgium
frequent
detect
tabl
sporad
isol
obtain
also
unit
kingdom
greec
bulgaria
higher
frequenc
detect
decaro
et
al
ntafi
et
al
filipov
et
al
oldest
strain
isol
decaro
et
al
thu
provid
evid
variant
circul
germani
year
first
detect
itali
sequenc
analysi
cpv
strain
obtain
larg
crosssect
sampl
dog
present
sever
diarrhea
veterinarian
unit
kingdom
period
reveal
virus
type
found
clegg
et
al
outsid
europ
three
variant
well
repres
tunisia
touihri
et
al
type
isol
predomin
north
america
hong
et
al
kapil
et
al
wherea
widespread
south
america
perez
et
al
calderon
et
al
except
brazil
circul
strain
characteris
castro
et
al
predomin
variant
asia
kang
et
al
ohshima
et
al
nandi
et
al
australia
meer
et
al
although
strain
detect
india
tabl
least
six
seven
aa
chang
fpv
least
five
six
aa
chang
variant
origin
type
tabl
aa
differ
sequenc
fpv
account
import
antigen
biolog
chang
eg
host
rang
shift
make
cpv
import
model
studi
viru
evolut
hueffer
parrish
vitro
fpv
replic
effici
felin
cell
line
cpv
infect
effici
cell
canin
felin
origin
vivo
fpv
replic
dog
thymu
bone
marrow
without
shed
fece
origin
canin
viru
replic
cat
convers
type
variant
regain
abil
replic
vivo
felin
host
truyen
studi
interact
fpv
cpv
cellular
receptor
transferrin
receptor
type
reveal
fpv
specif
bind
felin
tfr
wherea
variant
bind
felin
canin
tfr
interestingli
antigen
variant
bind
canin
felin
tfr
less
effici
origin
palermo
et
al
case
felin
panleukopenia
caus
wild
domest
felid
report
differ
part
world
truyen
new
variant
first
case
report
cat
itali
noth
known
clinic
condit
hematolog
paramet
outcom
infect
battilani
et
al
recent
two
case
infect
cat
observ
countri
decaro
et
al
decaro
et
al
case
mild
form
diseas
evid
moder
modif
hematolog
paramet
neurolog
diseas
occur
one
cat
associ
concurr
intracrani
abscess
decaro
et
al
anoth
biolog
consequ
accumul
aa
chang
protein
increas
pathogen
variant
carmichael
comparison
origin
type
antigen
variant
report
shed
fece
much
higher
titer
caus
sever
diseas
addit
lower
viru
dose
seem
requir
effici
infect
experiment
infect
dog
differ
level
mda
show
shed
high
titer
fece
infect
dog
even
pup
mda
hemagglutinationinhibit
titer
may
becom
infect
decaro
et
al
pathogen
investig
two
litter
german
shepherd
natur
infect
decaro
et
al
pup
display
clinic
sign
parvovirosi
mucoid
wateri
diarrhea
transient
leukopenia
none
show
either
hemorrhag
diarrhea
vomit
recov
day
realtim
pcr
prolong
shed
day
observ
howev
benign
cours
infect
contrast
recent
find
indic
sever
diseas
induc
mutant
spibey
et
al
carri
experiment
infect
beagl
dog
field
isol
experiment
challeng
carri
princip
confirm
abil
exist
type
vaccin
prevent
clinic
sign
shed
howev
context
interest
six
infect
control
dog
becam
sever
ill
display
leukopenia
day
postinfect
three
euthan
remain
three
recov
requir
support
therapi
date
whether
greater
infect
virul
one
variant
other
well
establish
either
experiment
system
basi
field
observ
inde
reason
think
three
variant
similar
pathogenet
potenti
increas
depend
particular
field
condit
age
immunolog
statu
stress
factor
etc
commonli
cpv
infect
pup
prone
acquir
viru
concomit
wane
mda
green
decaro
press
adult
thought
resist
cpv
infect
due
agereduc
suscept
presenc
specif
immun
induc
vaccin
previou
often
subclin
infect
although
cpv
infect
gener
restrict
young
anim
recent
becom
issu
also
adult
dog
apart
person
observ
kapil
et
al
scientif
report
occurr
parvovirosi
adult
dog
mostli
associ
infect
decaro
et
al
decaro
et
al
one
episod
twoyearold
mix
breed
dog
sever
affect
consequ
infect
strain
mischaracteris
mean
mab
howev
molecular
characteris
pcrrflp
sequenc
analysi
protein
gene
abl
correctli
type
viru
true
martella
unpublish
data
anoth
outbreak
occur
breed
kennel
itali
affect
dog
age
month
year
lead
death
bernes
mountain
pregnant
bitch
decaro
et
al
case
diseas
induc
variant
describ
even
dog
display
fever
acceler
puls
respiratori
rate
abdomin
pain
vomit
hemorrhag
diarrhea
dramat
lymphopenia
howev
dog
recov
progress
despit
sever
diseas
decaro
et
al
outbreak
report
adult
dog
far
anim
undergon
full
vaccin
schedul
includ
booster
vaccin
yearli
basi
decaro
et
al
decaro
et
al
variant
outbreak
involv
younger
dog
vaccin
protocol
schedul
first
year
age
complet
kapil
et
al
perez
et
al
calderon
et
al
ntafi
et
al
castro
et
al
filipov
et
al
protect
elicit
base
vaccin
field
variant
still
repres
vexata
quaestio
current
opinion
highli
diverg
mani
author
suggest
old
base
vaccin
still
protect
variant
current
circul
field
opposit
side
research
believ
immun
induc
vaccin
effect
homolog
vaccin
viru
significantli
lower
variant
thu
allow
aggress
strain
caus
infect
even
mortal
dog
regularli
vaccin
shown
oneway
crossreact
antigen
variant
origin
sera
rais
display
lower
viru
neutral
vn
titer
heterolog
viru
comparison
obtain
sera
rais
run
origin
similar
experi
carri
evalu
serolog
crossreact
antigen
variant
sera
dog
rabbit
caval
et
al
anim
administ
show
signific
lower
vn
antibodi
titer
heterolog
virus
respect
homolog
viru
find
confirm
crosshemagglutin
inhibit
studi
conduct
dog
ohshima
et
al
guinea
pig
kang
et
al
despit
measur
differ
strain
recognit
studi
shown
oldtyp
vaccin
abl
protect
dog
next
challeng
experiment
condit
spibey
et
al
siedek
et
al
howev
experi
challeng
carri
control
condit
week
vaccin
antibodi
commonli
reach
highest
level
decaro
et
al
noth
know
protect
induc
origin
type
well
variant
long
period
interv
vaccin
challeng
antibodi
titer
could
high
enough
effici
prevent
infect
diseas
caus
field
strain
addit
one
studi
dog
vaccin
clinic
protect
challeng
virul
variant
viru
shed
challeng
viru
thu
prove
suscept
infect
siedek
et
al
take
account
concern
antigen
differ
origin
type
variant
may
decreas
effect
base
vaccin
extens
use
vaccin
prepar
strain
circul
field
type
suggest
martella
et
al
caval
et
al
decaro
et
al
decaro
et
al
ohshima
et
al
calderon
et
al
ntafi
et
al
castro
et
al
nevertheless
even
consid
case
report
vaccin
failur
definit
evid
absenc
crossprotect
clinic
diseas
old
variant
cpv
thu
primari
caus
widespread
viru
circul
despit
extens
vaccin
still
repres
either
interfer
mda
vaccin
pup
poor
effici
immun
system
old
dog
consequ
emerg
variant
felin
popul
similar
debat
arisen
real
efficaci
tradit
fpvbase
vaccin
infect
caus
recent
studi
gamoh
et
al
fpvbase
vaccin
abl
crossprotect
subsequ
infect
virul
strain
howev
studi
two
vaccin
cat
use
challeng
short
period
administr
second
vaccin
dose
therefor
even
acknowledg
addit
studi
requir
address
issu
develop
multival
vaccin
contain
fpv
combin
cpv
variant
strain
serious
consid
decaro
et
al
decaro
et
al
rapid
diagnosi
cpv
infect
especi
import
kennel
shelter
order
isol
infect
dog
prevent
secondari
infect
suscept
contact
anim
clinic
diagnosi
indecis
sever
viral
pathogen
may
caus
diarrhea
dog
coronavirus
adenovirus
morbillivirus
rotavirus
reovirus
norovirus
green
decaro
press
thu
suspect
clinic
case
alway
confirm
laboratori
test
sever
method
develop
laboratori
diagnosi
cpv
infect
usual
carri
fece
intestin
content
anim
dead
affect
dog
late
stage
infect
edtablood
sampl
proven
use
diagnosi
cpv
viremia
except
long
last
decaro
et
al
b
test
detect
viral
antigen
mean
antibodybas
method
suitabl
cpv
diagnosi
veterinari
practic
repres
test
avail
field
green
decaro
press
howev
sensit
like
tradit
diagnost
method
proven
inferior
molecular
assay
immunochromatograph
ic
test
compar
molecular
techniqu
show
rel
sensit
test
exceed
respect
nucleic
acidbas
method
wherea
specif
poor
sensit
ic
test
associ
low
amount
viru
shed
fece
late
stage
infect
andor
earli
presenc
high
cpv
antibodi
titer
gut
lumen
may
sequestr
viral
particl
recent
studi
compar
perform
three
differ
commerci
avail
antibodybas
test
rapid
detect
cpv
antigen
pcr
immunoelectron
microscopi
confirm
high
specif
low
sensit
antigendetect
kit
schmitz
et
al
take
advantag
close
genet
antigen
relationship
among
carnivor
parvovirus
inhous
test
system
develop
cpv
diagnosi
abl
detect
also
fpv
neuerer
et
al
surprisingli
concern
express
abil
inhospit
rapid
parvoviru
test
recognis
effici
new
variant
concern
took
account
circumstanti
evid
increas
rapid
test
failur
parallel
emerg
spread
kapil
et
al
almost
simultan
recommend
test
mab
contain
inhous
assay
addit
mutat
detect
strain
current
circul
hong
et
al
howev
ic
test
specimen
repres
three
cpv
variant
includ
sampl
contain
recent
identifi
detect
rate
variant
similar
thu
dissip
previou
concern
hypothes
never
demonstr
less
effici
test
detect
new
variant
decaro
et
al
altern
techniqu
hemagglutin
ha
viru
isol
vi
carri
special
laboratori
fresh
erythrocyt
requir
ha
test
caus
problem
relat
manag
hous
donor
pig
speci
erythrocyt
eg
cat
rhesu
monkey
red
cell
may
use
either
difficult
obtain
quantiti
requir
expens
nevertheless
clear
read
ha
test
good
qualiti
erythrocyt
ensur
sinc
test
affect
alter
coeffici
erythrocyt
sediment
may
occur
case
stress
diseas
donor
pig
furthermor
strain
lack
ha
activ
report
nevertheless
ha
test
carri
plate
format
allow
rapid
process
mani
sampl
result
read
h
vi
requir
avail
cell
cultur
propag
laboratori
special
personnel
cell
cultur
capabl
moreov
vi
timeconsum
requir
long
incub
period
day
addit
test
immunofluoresc
ha
order
detect
viral
antigen
main
disadvantag
ha
vi
howev
low
sensit
like
due
antibodi
intestin
lumen
infect
dog
may
bind
virion
prevent
ha
viral
attach
cell
receptor
demonstr
natur
decaro
et
al
experiment
decaro
et
al
infect
cpv
detect
ha
vi
day
postinfect
wherea
techniqu
may
give
falseneg
result
despit
high
amount
viral
dna
detect
realtim
pcr
analysi
simpler
ha
protocol
design
slide
agglutin
test
also
propos
detect
cpv
variant
fecal
intestin
sampl
test
seem
overcom
limit
classic
method
marulappa
kapil
electron
microscopi
identif
parvoviruslik
morpholog
poorli
sensit
although
possibl
concentr
viral
particl
mean
specif
antibodi
immunoelectron
microscopi
techniqu
viral
antigen
also
detect
mean
immunohistochemistri
carri
intestin
brain
tongu
section
green
decaro
press
molecular
method
gener
affect
host
immun
respons
gener
timeconsum
labourintens
need
expertis
specialist
nucleic
acid
hybrid
assay
avail
sinc
earli
remond
et
al
subsequ
sever
pcr
assay
develop
display
increas
sensit
specif
comparison
tradit
method
loopmedi
isotherm
amplif
assay
also
propos
recent
year
altern
pcrbase
method
cho
et
al
howev
none
nucleicacid
detect
method
design
quantit
although
time
consum
contain
certain
risk
carryov
contamin
especi
high
sampl
throughput
requir
realtim
pcr
assay
base
taqman
technolog
develop
rapid
specif
sensit
detect
cpv
dna
decaro
et
al
realtim
pcr
sever
advantag
convent
pcr
allow
larg
increas
throughput
enabl
simultan
process
sever
sampl
realtim
pcr
run
format
mani
step
assay
autom
inexpens
quick
method
use
dna
prepar
base
boil
fecal
homogen
total
time
request
analysi
sampl
h
convent
realtim
pcr
respect
decaro
et
al
high
sensit
reproduc
realtim
pcr
assay
may
allow
identif
dog
shed
cpv
low
titer
fece
help
adopt
adequ
measur
prophylaxi
prevent
cpv
infect
especi
kennel
shelter
viru
often
respons
dramat
epizoot
establish
taqman
assay
success
employ
pathogenesi
studi
carri
natur
decaro
et
al
experiment
decaro
et
al
infect
also
use
evalu
viru
distribut
differ
tissu
decaro
et
al
taqman
realtim
rtpcr
assay
develop
detect
cpv
rna
transcript
demonstr
presenc
replic
viru
cn
elia
et
al
sybr
greenbas
realtim
pcr
assay
propos
altern
method
taqman
technolog
display
detect
limit
copi
viral
dna
except
discrimin
vaccin
field
virus
viru
strain
determin
may
limit
interest
practition
take
account
prognosi
treatment
cpv
enter
mainli
support
disregard
involv
variant
howev
viru
characteris
particular
interest
epidemiolog
point
view
method
use
characteris
cpv
strain
perform
highli
specialis
laboratori
diagnosi
cpv
infect
easili
feasibl
use
innov
techniqu
pcr
realtim
pcr
identif
viral
type
sometim
indecis
one
method
often
requir
definit
predict
antigen
specif
sever
decad
method
avail
characteris
cpv
strain
hemagglutin
inhibit
hi
use
mab
panel
four
mab
develop
antigen
characteris
fpv
assess
hi
reactiv
type
differ
lack
reactiv
mab
howev
mab
abl
recognis
even
recent
mab
develop
differenti
new
variant
type
cpv
nakamura
et
al
howev
mab
analysi
appli
fecal
sampl
optim
ha
activ
cpv
isol
obtain
cell
cultur
specimen
ha
titer
characteris
sever
sampl
high
cpv
dna
titer
test
neg
poorli
posit
ha
decaro
et
al
desario
et
al
moreov
haneg
sampl
success
amplifi
cell
cultur
order
increas
ha
titer
genotyp
pcr
system
develop
pereira
et
al
due
limit
number
nucleotid
variat
type
type
primer
select
take
advantag
two
singl
nucleotid
polymorph
snp
determin
replac
asparagin
aspart
acid
posit
isoleucin
valin
posit
type
respect
tabl
primer
select
one
mutat
end
nucleotid
mismatch
occur
end
primer
highli
detriment
primer
extens
strongli
decreas
pcr
amplif
howev
mismatch
albeit
present
end
primer
suffici
complet
prevent
amplif
cpv
type
martella
person
observ
moreov
current
circul
type
strain
mutat
v
due
nucleotid
chang
martella
et
al
therefor
pcrbase
genotyp
system
develop
pereira
colleagu
pereira
et
al
longer
abl
discrimin
type
type
strain
almost
novel
type
strain
go
mischaracter
type
final
typespecif
pcr
assay
type
cpv
detect
sinc
substitut
due
chang
third
codon
posit
nucleotid
mutant
erron
recognis
type
pcr
strategi
address
point
pcrrflp
assay
use
enzym
mboii
develop
proven
use
discrimin
type
howev
rflp
analysi
abl
differenti
sinc
type
remain
undigest
mboii
digest
addit
strain
detect
hungari
erron
recogn
method
due
constant
point
mutat
gene
introduc
mboii
restrict
site
demet
et
al
therefor
sequenc
analysi
could
predict
definit
viral
type
type
sampl
neg
ha
digest
give
mislead
result
pcrrflp
lead
remark
increas
cost
time
loss
sequenc
analysi
give
ampl
inform
cpv
type
sinc
fragment
amplifi
convent
pcr
use
primer
pair
encod
least
one
inform
aa
residu
protein
thu
allow
differenti
old
type
effort
speed
routin
analysi
two
realtim
pcr
assay
base
mgb
probe
technolog
design
order
recogn
snp
tabl
exist
type
type
codon
protein
decaro
et
al
decaro
et
al
assay
found
highli
sensit
reproduc
comparison
tradit
type
method
mgb
probe
assay
labourand
timesav
fact
format
autom
step
allow
simultan
process
sever
sampl
ensur
direct
characteris
cpv
variant
within
coupl
hour
consid
assay
run
parallel
plate
recent
strain
uncharacteris
mgb
probe
assay
report
decaro
et
al
strain
display
noncod
mutat
probe
bind
region
prevent
correct
hybrid
typespecif
probe
find
highlight
need
updat
cpvtype
method
base
snp
addit
mutat
may
hinder
correct
strain
characteris
reinforc
previou
suggest
keep
use
diagnost
molecular
tool
target
conserv
region
avoid
falseneg
result
decaro
et
al
accordingli
untyp
sampl
found
cpv
posit
use
taqman
assay
abl
detect
cpv
type
flpv
well
decaro
et
al
decaro
et
al
similar
concern
recent
express
american
scientist
detect
type
strain
chang
locat
near
critic
codon
kapil
et
al
albeit
present
within
target
region
mgb
assay
mutat
prevent
correct
strain
characteris
includ
primerprob
bind
site
inde
us
strain
display
chang
hong
et
al
submit
assay
correctli
recognis
type
probe
decaro
et
al
diagnosi
cpv
infect
may
ambigu
carri
fecal
sampl
dog
present
diarrhea
day
vaccin
fact
modifiedl
viru
contain
vaccin
abl
replic
intestin
mucosa
vaccin
dog
despit
unnatur
rout
administr
intramuscular
subcutan
instead
oronas
shed
fece
albeit
low
titer
shorter
time
period
respect
field
strain
decaro
et
al
circumst
detect
nucleic
acid
convent
assay
ict
ha
vi
pcr
fece
vaccin
dog
could
provid
falseposit
result
lead
misdiagnosi
diseas
probabl
caus
enter
pathogen
dog
moreov
would
import
rule
vaccineinduc
diseas
due
regain
virul
vaccin
viru
cpv
vaccin
except
safe
case
vaccineinduc
diseas
anecdot
report
never
clearli
demonstr
howev
consid
revers
virul
cpv
vaccin
theoret
occur
viru
strain
determin
requir
least
gastroenter
occur
day
cpv
vaccin
cpv
characteris
use
tradit
techniqu
often
inconclus
sinc
simultan
infect
type
vaccin
wildtyp
viru
may
mislead
result
hi
mab
pcrrflp
sequenc
analysi
address
point
pcrbase
approach
propos
senda
et
al
take
advantag
two
snp
determin
replac
methionin
leucin
posit
alanin
glycin
posit
old
wildtyp
strain
respect
tabl
howev
experi
mutat
suffici
prevent
complet
amplif
oldtyp
viru
vaccin
person
observ
moreov
sampl
contain
vaccin
wildtyp
strain
amplifi
success
pcrbase
strategi
abl
detect
simultan
presenc
two
virus
fece
mgb
probe
assay
develop
rapid
characteris
cpv
strain
decaro
et
al
decaro
et
al
discrimin
old
type
type
even
sequenc
analysi
protein
gene
inconclus
mislead
unless
sequenc
sever
clone
carri
pcr
may
select
effici
amplifi
either
virus
one
remain
undetect
subsequ
sequenc
analysi
overcom
limit
exist
method
mgb
probe
assay
decaro
et
al
establish
abl
discrimin
type
vaccin
variant
field
strain
basi
snp
respons
chang
isoleucin
threonin
residu
tabl
thu
sampl
collect
vaccin
dog
characteris
test
novel
mgb
probe
assay
order
assess
whether
true
type
field
strain
vaccin
old
type
viru
compani
europ
licens
type
vaccin
although
moment
vaccin
use
wide
problem
may
aris
analys
sampl
collect
dog
administ
type
vaccin
use
type
mgb
probe
assay
decaro
et
al
type
vaccin
virus
shed
fece
would
recogn
probe
specif
cpv
variant
characteris
field
strain
instead
vaccin
strain
similarli
type
assay
abl
distinguish
type
vaccin
field
strain
sinc
nucleotid
encount
bind
region
type
probe
decaro
et
al
consequ
addit
two
mgb
probe
assay
design
precis
differenti
strain
circul
field
contain
commerci
avail
vaccin
decaro
et
al
author
knowledg
develop
assay
abl
detect
vaccin
strain
avail
least
european
market
addit
vaccin
contain
differ
cpv
strain
licens
futur
test
establish
ensur
vaccin
strain
determin
establish
assay
use
address
controversi
aris
dog
owner
veterinarian
vaccin
compani
diarrhea
occur
within
day
cpv
vaccin
administr
molecular
assay
discrimin
vaccin
field
virus
success
appli
fecal
sampl
collect
dog
display
acut
gastroenter
shortli
cpv
vaccin
decaro
et
al
result
show
case
cpv
field
strain
differ
dog
pathogen
incub
moment
vaccin
thu
rule
revers
virul
vaccin
virus
fpv
sinc
first
identif
undergon
signific
chang
antigen
biolog
properti
decaro
et
al
cpv
progress
evolv
partli
posit
select
shackelton
et
al
decaro
et
al
show
genom
substitut
rate
similar
rna
virus
valu
substitut
per
site
per
year
shackelton
et
al
evolut
lead
emerg
antigen
variant
seem
virul
origin
type
contrast
despit
anecdot
report
claim
higher
pathogen
evid
differ
virul
variant
thu
extent
antigen
variant
identifi
mous
monoclon
antibodi
repres
clinic
relev
immunolog
event
still
determin
time
concern
real
efficaci
vaccin
antigen
variant
mainli
base
vitro
crossneutr
assay
might
even
neglig
vivo
inde
apart
welldocu
case
report
experiment
data
field
observ
seem
suggest
great
major
infect
still
occur
puppi
time
mda
wane
anim
becom
suscept
strain
viru
conclus
continu
evolut
cpv
accumul
point
mutat
viral
genom
present
two
differ
equal
import
implic
emerg
new
antigen
variant
display
differ
biolog
antigen
properti
may
requir
extens
revis
vaccin
programm
updat
viral
strain
contain
commerci
avail
product
ii
sophist
molecular
method
abl
detect
characteris
cpv
strain
base
perfect
match
viral
dna
assay
oligonucleotid
may
affect
onset
point
mutat
therefor
updat
well
thu
continu
epidemiolog
surveil
need
detect
new
cpv
variant
potenti
escap
host
immun
system
detect
method
